BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Genesis Bioventures (GBIW) Announces Name Change to Abviva, Inc.


12/7/2007 11:45:35 AM

LOS ANGELES--(BUSINESS WIRE)--Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that it has completed its planned name change of the corporation to Abviva, Inc. Genesis Bioventures changed its corporate name to Abviva, Inc. to emphasize its mission to commercialize the Mammastatin Serum Assay (“MSA”) and to pursue development of the mammastatin protein as a possible first line therapy against breast cancer. The name change was approved by the shareholders at the 2007 Annual Shareholders Meeting held on September 14, 2007 as part of the Company’s completion of its reorganization and restructuring plan.

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->